Brief: Oncozenge Receives Investment Capital From Yangtian Bio-Pharmaceutical
11/07/2025 10:21
July 11 (Reuters) - Oncozenge AB ONCOZ.ST: RECEIVES INVESTMENT CAPITAL FROM YANGTIAN BIO-PHARMACEUTICAL RECEIVES FIRST TWO INVESTMENT TRANCHES OF SEK 6 MILLION Source text: ID:nWkrc3BRb2 Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))